Pharma’s AI Evolution: Balancing Innovation, Transparency, and Regulation
October 8th 2025As AI adoption accelerates across life sciences, Shawn Opatka, VP and GM of Honeywell Life Sciences, and Linda Malek, partner at Crowell & Moring, discuss how regulatory expectations and federal initiatives—like the White House AI Action Plan—are shaping the technology’s future role in pharma quality, traceability, and healthcare systems.
Eli Lilly Invests Over $1 Billion to Strengthen Manufacturing and Supply Capabilities in India
October 7th 2025The investment will establish a new hub overseeing contract manufacturing across India and expand Lilly’s global supply of medicines for Alzheimer’s, diabetes, obesity, and cancer, amid shifting US trade and tariff policies.
LogiPharma USA 2025: Collaboration Takes Center Stage in Specialty Therapy Supply Chains
October 6th 2025Ammie McAsey, SVP of Supply Chain Operations, McKesson, emphasizes the critical role of collaboration, technology, and partnerships in ensuring advanced and specialty therapies reach patients safely and effectively.
GS1 US Pushes for Intelligent Data Capture to Strengthen Supply Chain Efficiency and Transparency
October 6th 2025A new report underscores how 2D barcodes and automated data capture powered by GS1 standards can help logistics and life sciences companies overcome outdated systems, labeling issues, and visibility gaps.